Suppr超能文献

替诺福韦诱发的HIV感染患者低磷性骨软化症

Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients.

作者信息

Mateo Lourdes, Holgado Susana, Mariñoso Maria Luisa, Pérez-Andrés Ricard, Bonjoch Anna, Romeu Joan, Olivé Alejandro

机构信息

Rheumatology Service, University Hospital Germans Trias i Pujol, Carretera del Canyet s/n, Badalona, Barcelona, 08916, Spain.

Pathology Service, Hospital del Mar, Barcelona, Spain.

出版信息

Clin Rheumatol. 2016 May;35(5):1271-9. doi: 10.1007/s10067-014-2627-x. Epub 2014 May 3.

Abstract

Tenofovir disoproxil fumarate (TDF) is an adenine analogue reverse transcription inhibitor widely used in first-line treatment of human immunodeficiency virus (HIV) infection and also in hepatitis B virus infection. Its use has been linked to sporadic Fanconi syndrome, renal failure and bone disease. We present the clinical characteristics of tenofovir-induced osteomalacia, discuss bone biopsy findings, describe predisposing factors and compare our results with other reported cases. We describe five cases of hypophosphatemic osteomalacia induced by TDF and recorded at the rheumatology service of a university hospital between 2010 and 2014. We also report the characteristics of bone biopsies of this pathology, which have not been previously described. We include a review of published cases of proximal renal tubulopathy (PRT) and osteomalacia induced by TDF (PubMed 1995-2014; keywords: osteomalacia, tenofovir, Fanconi syndrome, hypophosphatemic osteomalacia, proximal renal tubulopathy, bone biopsy). Five HIV patients who developed hypophosphatemic osteomalacia under TDF treatment (>5 years) presented increasing bone pain and a progressive inability to walk without assistance as a result of multiple insufficiency fractures. Bone biopsy performed in three patients after tetracycline labelling showed increased osteoid thickness, confirming osteomalacia. A literature review retrieved 17 publications on this condition, including 53 cases: 26 patients developed isolated PRT, 25 presented PRT and with multiple insufficiency fractures and two presented isolated bone disease, including osteomalacia and osteoporosis. Rheumatologists should be alert to this complication in patients receiving tenofovir. The main complaint reported by these patients is diffuse pain, predominantly in the lower limbs, indicating multiple stress fractures. Serum phosphate and appropriate screening for abnormal proximal tubule function should be monitored. Bone scintigraphy should be carried out in cases of limb pain before the occurrence of more severe complications.

摘要

富马酸替诺福韦二吡呋酯(TDF)是一种腺嘌呤类似物逆转录抑制剂,广泛用于人类免疫缺陷病毒(HIV)感染的一线治疗以及乙型肝炎病毒感染的治疗。其使用与散发性范科尼综合征、肾衰竭和骨病有关。我们介绍了替诺福韦诱发骨软化症的临床特征,讨论了骨活检结果,描述了易感因素,并将我们的结果与其他报道的病例进行了比较。我们描述了2010年至2014年间在一所大学医院的风湿病科记录的5例由TDF诱发的低磷性骨软化症病例。我们还报告了这种病理状况的骨活检特征,此前尚未有过描述。我们对已发表的由TDF诱发的近端肾小管病(PRT)和骨软化症病例进行了综述(PubMed 1995 - 2014;关键词:骨软化症、替诺福韦、范科尼综合征、低磷性骨软化症、近端肾小管病、骨活检)。5例在TDF治疗(>5年)期间出现低磷性骨软化症的HIV患者,由于多处不全骨折,骨痛逐渐加重,且逐渐无法独立行走。3例患者在四环素标记后进行的骨活检显示类骨质厚度增加,证实为骨软化症。文献综述检索到17篇关于这种情况的出版物,包括53例病例:26例患者出现孤立性PRT,25例同时出现PRT和多处不全骨折,2例出现孤立性骨病,包括骨软化症和骨质疏松症。风湿病学家应对接受替诺福韦治疗的患者的这种并发症保持警惕。这些患者报告的主要症状是弥漫性疼痛,主要在下肢,提示多处应力性骨折。应监测血清磷酸盐水平,并适当筛查近端肾小管功能异常。在出现更严重并发症之前,对于肢体疼痛的病例应进行骨闪烁扫描。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验